Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

SARDA PROTEINS LTD. - 519242 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to Regulation 39(3) of Security and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company has received the enclosed register from our RTA -Link Intime India Private Limited, regarding the duplicate share certificates of the Company that have been issued. Pursuant to the SEBI Circular No. SEBI/HO/MJRSD/MIRSD _ RTAMB/P/2022/8 dated January 25, 2022, a letter of confirmation will be issued to the securities holder / claimant upon completion of necessary procedures regarding duplicate share certificates.
02-02-2023
Bigul

SARDA PROTEINS LTD. - 519242 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

 Pursuant to Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing the extract of Un-audited Financial Results for the quarter and nine months ended on 31st December, 2022 published by the Company in The Indian Express (English) and Nafa Nuksan (Hindi) Newspaper on 31st January, 2023.
31-01-2023
Bigul

SARDA PROTEINS LTD. - 519242 - Appointment Of Mr. Somya Data As The Chief Financial Officer (CFO) Of The Company

 Pursuant to Regulation 30(2) read with Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), we hereby inform that based on the recommendation of Nomination and Remuneration Committee, the Board of Directors of the Company, at its meeting held on Monday, 30th January, 2023 has appointed Mr. Somya Data as the Chief Financial Officer (CFO) of the Company with effect from 01st February, 2023. Further, the details of the aforesaid Chief Financial Officer (CFO) required under Regulation 30 read with Part A of Schedule III of the Listing Regulations read with SEBI Circular CIR/CFD/CMD/4/2015 dated September 09, 2015 has been attached herewith as Annexure-A.
30-01-2023
Bigul

SARDA PROTEINS LTD. - 519242 - Un-Audited Financial Results Of The Company For The Quarter And Nine Months Ended On 31St December, 2022 And Limited Review Report Thereon.

 In accordance with Regulation 33 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are submitting herewith the Un-audited Financial Results of the Company for the quarter and nine months ended on 31st December, 2022 and Limited Review Report on Un-audited Financial Results for the quarter and nine months ended on 31st December, 2022.
30-01-2023
Bigul

SARDA PROTEINS LTD. - 519242 - Board Meeting Outcome for For Approval Of The Un-Audited Financial Results Of The Company For The Quarter And Nine Months Ended On 31Th December, 2022 And Took On Record The Limited Review Report Thereon.

 1.Approved the Un-audited Financial Results of the company for the quarter and nine months ended on 31th December, 2022 and took on record the Limited Review Report thereon. Further, the extract of the Un-audited Financial Results would also be published in the newspapers in compliance with Regulation 47 of Listing Regulations; 2.Took note of the Resignation of Mr. Himanshu Gupta from the post of Chief Financial Officer (CFO) of the company with effect from closure of business hours on 30th January, 2023; and 3.Approved the appointment of Mr. Somya Data as the Chief Financial Officer (CFO) of the company with effect from 01st February, 2023. Further, the brief profile and other details in accordance with SEBI circular CIR/CFD/CMD/4/2015 dated 09.09.2015 to be provided separately.
30-01-2023
Bigul

SARDA PROTEINS LTD. - 519242 - Board Meeting Intimation for Approval Of The Un-Audited Financial Results Of The Company For The Quarter And Nine Months Ended On 31St December, 2022

 SARDA PROTEINS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/01/2023 ,inter alia, to consider and approve Pursuant to the provisions of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby intimate that a meeting of the Board of Directors of the Company is scheduled to be held on Monday, 30th January, 2023 at 12:00 P.M. at the Corporate Office of the company situated at Inside Data Ingenious Global Limited, Station Road, Durgapura, Jaipur-302018 (Rajasthan) inter alia: i. To approve the Un-audited Financial Results of the company for the quarter and nine months ended on 31st December, 2022; ii. To take on record the Limited Review Report on the Un-audited Financial Results for the quarter and nine months ended on 31st December, 2022.
23-01-2023
Bigul

SARDA PROTEINS LTD. - 519242 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Registrar and Share Transfer Agent of the Company i.e. M/s. Link Intime India Private Limited has received below mentioned information about loss of share certificates from the Shareholder. The duplicate share certificates/Letter of Confirmation will be issued only after the receipt of all necessary documents from the Shareholder.
23-01-2023
Bigul

SARDA PROTEINS LTD. - 519242 - Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)

 In terms of Regulation 30(2) read with Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform that the Company has received Resignation letter dated 19th January, 2023 from Mr. Himanshu Gupta, Chief Financial Officer (CFO) of the Company informing about his resignation from the post of Chief Financial Officer (CFO) due to some personal reasons with effect from closure of business hours of 30th January, 2023. Further, the details of the aforesaid Chief Financial Officer (CFO) required under Regulation 30 read with Part A of Schedule III of the Listing Regulations read with SEBI Circular CIR/CFD/CMD/4/2015 dated September 09, 2015 has been attached herewith as Annexure-A.
19-01-2023
Bigul

SARDA PROTEINS LTD. - 519242 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 We hereby enclose herewith the Certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018 for the quarter ended on 31st December, 2022 received from M/s Link Intime India Private Limited, Registrar and Share Transfer Agent (RTA) of the Company.
09-01-2023
Bigul

SARDA PROTEINS LTD. - 519242 - Closure of Trading Window

 This is to inform you that pursuant to Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 (as amended) read with the Company''s Code of Conduct to regulate, monitor and report trading, the Trading Window for trading in the securities of the Company shall remain closed for Designated Persons of the Company and their relatives from 01st January, 2023 till 48 hours after the announcement of the Financial Results of the Company for the quarter and nine months ended on 31st December, 2022. The date of meeting of the Board of Directors to approve the Financial Results of the Company for the quarter and nine months ended on 31st December, 2022 will be informed in due course.
29-12-2022
Next Page
Close

Let's Open Free Demat Account